February 2016 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for February 2016. This roundup includes...
Uric Acid Levels Low in Teens With Type 1 Diabetes
Unlike in adults, there is no association between uric acid, cardiorenal parameters
Anti-VEGF Agents Linked to Visual Acuity Improvement in DME
From baseline to two years, improvement noted with three anti-VEGF agents
Air Pollution Tied to Adverse Effect on Metabolic Parameters
Adverse effects on glucose tolerance, insulin sensitivity, blood lipids in Mexican-Americans
Dispositional Mindfulness Tied to Improved Glucose Regulation
In adjusted analyses, no correlation for mindfulness with prevalence of type 2 diabetes
Drop-to-Drop Variation Seen With Fingerprick Blood
Authors say variation in blood analytes holds implications for point-of-care testing
Suggestions for Optimizing Practice Feedback Effectiveness
Practice feedback interventions relate to nature of desired action, feedback display, delivery of feedback
Plasma Branched-Chain Amino Acids Linked to Insulin Sensitivity
Correlation significantly modified by ethnicity; only significant in Caucasians and Hispanics
G-Pen May Aid Hypoglycemia With Type 1 Diabetes
The mini-dose glucagon may provide more precise treatment than oral carb
Calcium Channel Blockers Lower Fasting Glucose in Diabetes
CCB, especially verapamil, use linked to lower fasting blood glucose levels in adults with diabetes
